Because the CONCERTA tablet is nondeformable and does not appreciably alter in form in the GI tract, CONCERTA shouldn't ordinarily be administered to patients with preexisting critical gastrointestinal narrowing (pathologic or iatrogenic, by way of example: esophageal motility disorders, tiny bowel inflammatory sickness, "brief gut" syndrome becaus